MMP2 and neoplasm: For an example of a PEG-based protease-responsive nanotherapeutic, PEG-functionalized QDs clusters sensitive to MMP-2 were developed to enable multistage penetration into tumor tissue [320], with their initial 100 nm size promoting accumulation in the tumor, followed by cleavage into 10 nm particles that could more readily diffuse in the tumor.